<< Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells | TENS therapy is not effective against chronic low-back pain >>

Endo Pharmaceuticals to reviews its products and development programs at Annual Healthcare Conference

Published on December 31, 2009 at 3:45 AM · No Comments

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, at 10:00 a.m. PST. David Holveck, president and chief executive officer of Endo, will review the company's products and development programs.

The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section.

SOURCE Endo Pharmaceuticals

1dff750f-4a79-4b29-b47a-3d5a74578657|1|4.0

Posted in: Pharmaceutical News

Tags: Anti-Inflammatory, Cancer, Carcinoma, Endocrinology, Migraine, Neuralgia, Neurology, Oncology, Osteoarthritis, Prostate Cancer, Puberty, Urology, Voltaren

Genentech's vismodegib Phase II clinical study in advanced basal cell carcinoma meets primary endpointGenentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of it...
Amphetamines appear to increase risk of developing Parkinson's disease: New researchNew research shows people who have used amphetamines such as benzedrine and dexedrine appear to be a...
Natus announces acquisition of MedixNatus Medical Incorporated today announced that it has acquired Medix, a leader in the development, ...
Endocrine Society releases new clinical practice guideline on congenital adrenal hyperplasiaToday, The Endocrine Society released a new clinical practice guideline on the diagnosis and treatme...
Anika Therapeutics acquires Fidia Farmaceutici subsidiary FABAnika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. (“F...
Warner Chilcott begins cash tender offerWarner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") ...
Endo Pharmaceuticals reaches patent litigation settlement with LecTecEndo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on out...
Not enough is being done to support patients suffering from tinnitusAs many as one in seven people will experience tinnitus, or ringing in their ears, at some time of t...
New director appointed at the Saint John’s Neuroscience InstituteSaint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassa...
New book explores neurobiology of pleasureA sense of pleasure generated by the brain's hedonic neural systems is fundamental to daily life, an...
Inflammation of microglia may not be associated with dementia in Alzheimer's diseaseThe idea that anti-inflammatory drugs might protect people struggling with dementia from Alzheimer's...
Memorial Hospital, IU Cancer Center join in fight against cancerMemorial Hospital and Health Care Center and the Indiana University Cancer Center announced an affil...
Gleevec strangles drug-resistant, metastatic prostate cancerA medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cance...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.